Montelukast Prescribing at TELDOC
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
4,597
Total Quantity
177.7K
NHS Cost
£8.9K
vs National Avg
+571.4%
TELDOC prescribed 4,597 items of Montelukast over the last 12 months at a cost of £8,925 to the NHS. This is 571.4% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
375
Jun 2026
374
Jun 2026
385
Jun 2026
371
Jun 2026
419
Jun 2026
384
Jun 2026
398
Jun 2026
371
Jun 2026
380
Jun 2026
372
Jun 2026
367
Jun 2026
401
Prescribing Details
| Total Items | 4,597 |
|---|---|
| Total Quantity | 177,702 |
| Total NHS Cost | £8,925 |
| Presentations | 5 different forms |
| vs National Average | +571.4% |
Montelukast Prescribing Comparison
| This practice | 4,597 items |
|---|---|
| National average per practice | 685 items |
| Difference | +571.4% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.